Publicaciones en colaboración con investigadores/as de University of Aberdeen (41)

2024

  1. Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations

    Nature Medicine

  2. Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries

    Arthritis Care and Research

  3. Correction to: Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations (Nature Medicine, (2024), 10.1038/s41591-024-03209-x)

    Nature Medicine

  4. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis

    Health technology assessment (Winchester, England), Vol. 28, Núm. 47, pp. 1-119

  5. Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer: A Systematic Review

    European Urology Open Science, Vol. 63, pp. 126-135

  6. The Association of Dementia With Incident Adverse Drug Reactions in Hospitalized Older Adults

    Journal of the American Medical Directors Association, Vol. 25, Núm. 9

2023

  1. Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation

    ESMO Open, Vol. 8, Núm. 4

  2. Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program

    International Journal of Surgery Protocols, Vol. 27, Núm. 3, pp. 122-129

2022

  1. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

    Journal of the National Cancer Institute, Vol. 114, Núm. 1, pp. 109-122

  2. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805

  3. The first international Delphi consensus statement on Laparoscopic Gastrointestinal surgery: Laparoscopic GI Surgery Consensus

    International Journal of Surgery, Vol. 104

2021

  1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

    Nature Communications, Vol. 12, Núm. 1

2020

  1. A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens

    Cancer Cytopathology, Vol. 128, Núm. 12, pp. 928-938

  2. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)

    European Urology

  3. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†[Formula presented]: Under the Auspices of the EAU-ESMO Guidelines Committees

    European Urology, Vol. 77, Núm. 2, pp. 223-250

  4. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

2019

  1. An international study of the quality of life of adult patients treated with home parenteral nutrition

    Clinical Nutrition, Vol. 38, Núm. 4, pp. 1788-1796

  2. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

    Annals of Oncology, Vol. 30, Núm. 11, pp. 1697-1727

  3. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

2017

  1. Programmed death-ligand 1 immunohistochemistry testing: A review of analytical assays and clinical implementation in non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 35, Núm. 34, pp. 3867-3876